作者回复：丙型肝炎病毒血症供体用于丙型肝炎病毒阴性受者的地域差异。 - Suppr | 超能文献

The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.

作者信息

Cotter Thomas G, Charlton Michael

机构信息

Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX.

The Center for Liver Diseases, University of Chicago Medicine, Chicago, IL.

出版信息

Transplantation. 2022 Feb 1;106(2):e166. doi: 10.1097/TP.0000000000003939.

DOI:10.1097/TP.0000000000003939

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.作者回复：丙型肝炎病毒血症供体用于丙型肝炎病毒阴性受者的地域差异。

Transplantation. 2022 Feb 1;106(2):e166. doi: 10.1097/TP.0000000000003939.

2

Geographic Variation in the Utilization of HCV-viremic Donors into HCV-negative Recipients.丙型肝炎病毒血症供体用于丙型肝炎病毒阴性受者的地理差异。

Transplantation. 2022 Feb 1;106(2):e165. doi: 10.1097/TP.0000000000003938.

3

Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.美国 HCV 病毒血症供体向 HCV 阴性受者进行肝移植：频率增加，地域差异显著。

Transplantation. 2021 Jun 1;105(6):1285-1290. doi: 10.1097/TP.0000000000003382.

4

Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.在当代，丙型肝炎阳性供心的利用率和临床结局。

J Heart Lung Transplant. 2019 Sep;38(9):907-917. doi: 10.1016/j.healun.2019.06.023. Epub 2019 Jun 28.

5

Heart Transplantation for Hepatitis C Virus Non-Viremic Recipients From Hepatitis C Virus Viremic Donors.丙型肝炎病毒血症供者向丙型肝炎病毒非血症受者进行心脏移植。

Cardiol Rev. 2019 Jul/Aug;27(4):179-181. doi: 10.1097/CRD.0000000000000255.

6

Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.将来自丙型肝炎病毒血症供体的肾脏移植给丙型肝炎病毒阴性受体后，基于索磷布韦的抗病毒治疗早期成功。

Transpl Infect Dis. 2019 Oct;21(5):e13146. doi: 10.1111/tid.13146. Epub 2019 Jul 31.

7

CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors.丙型肝炎病毒阴性肾移植受者接受丙型肝炎病毒血症供体和丙型肝炎病毒血症供体移植后的 CMV 特异性 T 细胞免疫反应。

Ren Fail. 2022 Dec;44(1):831-841. doi: 10.1080/0886022X.2022.2072744.

8

A real-world, single-center experience of the utilization of hepatitis C-viremic kidneys for hepatitis C-negative recipients.真实世界中，单中心利用丙型肝炎病毒血症供肾进行丙型肝炎病毒阴性受者肾移植的经验。

Clin Nephrol. 2021 Oct;96(4):216-225. doi: 10.5414/CN110487.

9

Utilization of Hepatitis C Virus (HCV)-Viremic Organs for HCV Negative Recipients: Is Practice Speeding Past the Evidence?丙型肝炎病毒（HCV）血症器官用于HCV阴性受者：实践是否超越了证据？

Hepatology. 2020 Jan;71(1):4-7. doi: 10.1002/hep.30933. Epub 2019 Dec 18.

10

Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.在 HCV 阳性供者肝移植到 HCV 阴性受者中增加利用率和优异的初始结果：HCV 阳性供者肝移植后的结果。

Hepatology. 2019 Jun;69(6):2381-2395. doi: 10.1002/hep.30540. Epub 2019 Apr 11.

引用本文的文献

1

Trends in candidate hepatitis C virus nucleic acid amplification test (NAT)+ listing and associated impacts on liver transplantation waitlist outcomes.丙型肝炎病毒核酸扩增检测（NAT）阳性候选人名单的趋势及其对肝移植等待名单结果的相关影响。

Am J Transplant. 2025 Apr;25(4):793-803. doi: 10.1016/j.ajt.2024.10.016. Epub 2024 Oct 24.